Skip to Content

Bortezomib Mylan 3.5 mg powder for solution for injection

Licence status
Authorised: 17/05/2019
Active substances
Bortezomib
Dosage Form
Powder for solution for injection
Licence number
PA0577/191/001
Licence holder
McDermott Laboratories Ltd., T/A Gerard Laboratories

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX32 bortezomib
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/05/2019

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie